Skip to main content

Table 2 Clinical metrics summary

From: Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia

Clinical metric Before PAE
Mean ± SD
12 months after PAE
Mean ± SD
24 months after PAE
Mean ± SD
P values
IPSS (points) 26.5 ± 5.0 18.0 ± 4.5 10.0 ± 4.0 < 0.01
QoL (points) 6.0 ± 1.0 4.0 ± 1.0 2.0 ± 1.0 < 0.01
Qmax (mL/sec) 8.0 ± 2.0 14.0 ± 5.0 18.0 ± 4.0 < 0.01
PVR (mL) 198 ± 20.0 152 ± 25.0 90 ± 15.0 < 0.01
PV (mL) 303 ± 20.0 258 ± 15.0 209 ± 15.0 < 0.01
PSA (ng/mL) 11.2 ± 2.5 9.5 ± 1.5 7.9 ± 1.5 < 0.05
  1. IPSS International Prostate Symptom Score, mL milliliter, PAE prostate artery embolization, PSA prostate specific antigen, PV prostate volume, PVR postvoid residual volume, Qmax peak flow rate, QoL urinary quality of life, SD standard deviation